These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4197329)

  • 21. [A new effective antihypertensive agent. Studies on 40 patients].
    Bott H; Lill G
    Med Welt; 1968 Mar; 13():834-6. PubMed ID: 4974637
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of DCR-515 in the treatment of arterial hypertension].
    da Cunha GP; Riskala R; Mulinari AS
    Hospital (Rio J); 1968 Dec; 74(6):2061-72. PubMed ID: 4977024
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical study with DCR-1015].
    Elizalde JE
    Hospital (Rio J); 1968 Oct; 74(4):1373-5. PubMed ID: 4974066
    [No Abstract]   [Full Text] [Related]  

  • 24. [Kidney function during therapy of hypertension].
    Kiesewetter E; Wohlzogen FX; Mostbeck A
    Int J Clin Pharmacol; 1973 Jul; 7(4):316-22. PubMed ID: 4199251
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of arterial hypertension patients with Bridina].
    Nogueira WP
    Hospital (Rio J); 1970 Aug; 78(2):501-10. PubMed ID: 4993258
    [No Abstract]   [Full Text] [Related]  

  • 26. [Combined and used therapy in arterial hypertension].
    Martínez Osorio L; Martín Trenor A
    Rev Clin Esp; 1967 May; 105(4):312-7. PubMed ID: 4973963
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical examination of a combined antihypersensitive agent containing hydrogenated ergot alkaloid].
    Wanner J
    Schweiz Med Wochenschr; 1968 Aug; 98(32):1196-201. PubMed ID: 4974016
    [No Abstract]   [Full Text] [Related]  

  • 28. Why and how to prevent atherosclerotic disease.
    Stamler J
    G Ital Cardiol; 1974; 4(1):95-112. PubMed ID: 4824632
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of cardiovascular diseases].
    Akhmeteli MA
    Kardiologiia; 1982 May; 22(5):47-54. PubMed ID: 7047855
    [No Abstract]   [Full Text] [Related]  

  • 30. [Real or alleged risks of clofibrate derivatives and certain risks of their prohibition].
    de Gennes JL
    Nouv Presse Med; 1979 Mar; 8(15):1223-5. PubMed ID: 375186
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experiences with a new antihypertensive agent].
    Stampfer E
    Wien Klin Wochenschr; 1971 Jan; 83(4):66-9. PubMed ID: 4994618
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (preliminary communication)].
    Elizalde JE
    Hospital (Rio J); 1968 Dec; 74(6):2073-5. PubMed ID: 4977025
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical experience using DCR-515 in the treatment of essential arterial hypertension (final communication)].
    Elizalde JE
    Hospital (Rio J); 1968 Dec; 74(6):2077-81. PubMed ID: 4977026
    [No Abstract]   [Full Text] [Related]  

  • 34. Can modification of risk factors reduce coronary heart disease?
    Grundy SM
    Cardiovasc Clin; 1983; 13(1):283-96. PubMed ID: 6336670
    [No Abstract]   [Full Text] [Related]  

  • 35. A pediatric approach to atherosclerosis prevention.
    Glueck CJ
    Curr Concepts Nutr; 1975; 3():101-11. PubMed ID: 165920
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effectiveness of the 5-year program of multi-factorial prevention of ischemic heart disease in men].
    Meĭmanaliev TS; Shleĭfer EA; Madaminov IaK; Gil'fanova VSh; Aĭtmurzaeva GT; Finger EM; Ismailova ChS; Koshaliev EK; Iaroslavtseva OS; Podgurskaia LP
    Sov Med; 1990; (12):57-9. PubMed ID: 2151491
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of clofibrate. The opinion of Prof. D. Kritchevsky].
    Fabbrocini V
    Minerva Cardioangiol; 1980 Nov; 28(11):759-60. PubMed ID: 7231692
    [No Abstract]   [Full Text] [Related]  

  • 38. Multifactorial trial in the prevention of coronary heart disease: 2. Risk factor changes at two and four years.
    Eur Heart J; 1982 Apr; 3(2):184-90. PubMed ID: 7084265
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes of risk factors as the result of the 2-year Coronary Disease Prevention Program in Warsaw].
    Rywik S; Szostak WB; Wagrowska H; Charzewska J; Kulesza W; Przestalska-Malkin H; Chabros E; Chotkowska E; Kuźmińska A; Polakowska M; Kupść W; Chwojnowska Z; Sobotowska M; Napierała M
    Pol Tyg Lek; 1982 Aug; 37(31):887-93. PubMed ID: 7155975
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experiences of 15 years in the screening of ischaemic heart diseases and arterial hypertension].
    Santrůcek M; Geizerová H; Hejl Z; Grafnetter D
    Z Gesamte Inn Med; 1975 Nov; 30(21):709-13. PubMed ID: 1210471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.